Location: Home
  • search
  • go
  • Relate News
  • 8/18/2021BeiGene and EUSA Pharma Announce NMPA Approval of QARZIBA (Dinutuximab...
  • 8/18/2021HiberCell Takes Over Gentility Science, Formerly Known as WuxiNextcode...
  • 8/18/2021Novartis Secures New Chinese Approval for Cosentyx (Secukinumab) in Pe...
  • 8/18/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation ...
  • 8/17/2021Amgen Secures Chinese Approval of Its Psoriasis Drug Otezla (Apremilas...
  • 8/17/2021CDE Solicits Comments on Technical Guidance for Clinical Trials of New...
  • 8/16/2021IQVIA Provides Snapshot and Outlook of County Level Healthcare Market
  • 8/16/2021Novo Nordisk Launches Once-Weekly Ozempic (Semaglutide) Injection in ...
  • 8/16/2021Incyte and InnoCare Announce Collaboration and License Agreement for T...
  • 8/16/2021CDE Solicits Comments on the Technical Guidance for Research and Evalu...
  • 8/15/2021PharmaDJ: China Strengthens Regulations for Clinical Use of Oncology D...
  • 8/13/2021China's Anti-Foreign Sanctions Law: How Businesses Should Prepare
  • 8/13/2021GC Pharma Announces GreenGene F Approval in China for the Treatment of...
  • 8/12/2021China Issues New Policy on Establishing the Medical Insurance Benefit ...
  • 8/12/2021NHC issues the Guidelines for Long Term Prescription Management (Inter...
  • 8/12/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation...
  • 8/11/2021China Approves Clinical Trial Mixing Covid-19 Vaccines from Sinovac an...
  • 8/11/2021Sinopharm Drops Plan to Take China TCM Holdings Private
  • 8/11/2021Bloomberg: China Signals Businesses Face Greater Regulation in Coming ...
  • 8/10/2021China's Healthcare Appears Ripe For Digitization
  • 8/10/2021Merck, Novo, Sanofi and More Pull Off China Growth Thanks to Price Man...
  • 8/10/2021Seagen and RemeGen Announce Exclusive Worldwide License and Co-Develop...
  • 8/10/2021HUTCHMED and Epizyme Announce Strategic Collaboration for TAZVERIK (ta...
  • 8/10/2021Chinese Vitamin C Price-fixing Lawsuit Tossed by U.S. Appeals Court
  • 8/10/2021PhaseBio and SFJ Pharma Announce Chinese IND Approval for Bentracimab
  • 8/8/2021Akeso/Sino Biopharma's PD-1 Penpulimab Granted Marketing Approval in C...
  • 8/6/2021Inmagene and Kissei Enter into an Exclusive License Agreement for Fost...
  • 8/6/2021Oyster Point Announces License Deal with Ji Xing Pharma for Novel Dry...
  • 8/6/2021Recent Executive Moves
  • 8/6/2021NHC Releases 2020 Annual Health Sector Development Report (Full Summa...
  • Page:94/367 Total number of articles:10986: [First][<<] [92] [93] [94] [95] [96] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group